131 results
S-1
EX-10.25
VIR
Vir Biotechnology Inc
3 Sep 19
IPO registration
4:40pm
the Platform Technology is included within Funded Developments.
“Global Access” means (a) the knowledge and information gained from the Global Health … to people most in need within Developing Countries.
“Global Access Commitments” has the meaning given in Section 3.
“Global Health Project” means the HIV
S-1
EX-10.26
VIR
Vir Biotechnology Inc
3 Sep 19
IPO registration
4:40pm
records and dedicated to the Project.
GLOBAL ACCESS COMMITMENT
You will conduct and manage the Project and the Funded Developments in a manner … that ensures Global Access. Your Global Access commitments will survive the term of this Agreement. “Funded Developments” means the products, services
S-1
EX-10.27
VIR
Vir Biotechnology Inc
3 Sep 19
IPO registration
4:40pm
or a separate bookkeeping account maintained as part of Your financial records and dedicated to the Project.
GLOBAL ACCESS COMMITMENT
You will conduct … and manage the Project and the Funded Developments in a manner that ensures Global Access. Your Global Access commitments will survive the term
DRS/A
EX-10.25
VIR
Vir Biotechnology Inc
7 Aug 19
Draft registration statement (amended)
12:00am
the Platform Technology is included within Funded Developments.
“Global Access” means (a) the knowledge and information gained from the Global Health … to people most in need within Developing Countries.
“Global Access Commitments” has the meaning given in Section 3.
“Global Health Project” means the HIV
DRS/A
EX-10.27
rvpqbf258g
7 Aug 19
Draft registration statement (amended)
12:00am
DRS/A
EX-10.26
lj6mclenwq45rkk
7 Aug 19
Draft registration statement (amended)
12:00am
8-K
8wi9 xyf8r3w46
29 May 20
Vir Biotechnology and Biogen Execute Agreement to ManufactureSARS-CoV-2 Antibodies for PotentialCOVID-19 Treatment
4:06pm
DEFA14A
1hvhhfy
6 Apr 20
Additional proxy soliciting materials
4:53pm
8-K
3snsm6xyt2
29 Sep 21
Other Events
5:13pm
DEFA14A
o6teth
8 May 20
Additional proxy soliciting materials
4:10pm
8-K
EX-99.1
3isxzk je6fu
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
DRS
EX-10.56
m76ueso3whbx
23 Jun 20
Draft registration statement
12:00am